Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.

Cancer Immunol Immunother · 2022 · PMC9519717 · PMID 35347395

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

close to significancep < 0.10so close (0.05 < p ≤ 0.1)

Variables that achieved statistical significance (p < 0.05) or were close to significance (p < 0.10) in the univariate analysis were examined in a multivariate analysis.

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.